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Cellular quiescence, defined as reversible growth/proliferation arrest, is thought to represent a homogenous state
induced by diverse anti-mitogenic signals. We used transcriptional profiling to characterize human diploid
fibroblasts that exited the cell cycle after exposure to three independent signals—mitogen withdrawal, contact
inhibition, and loss of adhesion. We show here that each signal caused regulation of a unique set of genes known to
be important for cessation of growth and division. Therefore, contrary to expectation, cells enter different quiescent
states that are determined by the initiating signal. However, underlying this diversity we discovered a set of genes
whose specific expression in non-dividing cells was signal-independent, and therefore representative of quiescence
per se, rather than the signal that induced it. This fibroblast ‘‘quiescence program’’ contained genes that enforced
the non-dividing state, and ensured the reversibility of the cell cycle arrest. We further demonstrate that one
mechanism by which the reversibility of quiescence is insured is the suppression of terminal differentiation.
Expression of the quiescence program was not simply a downstream consequence of exit from the cell cycle,
because key parts, including those involved in suppressing differentiation, were not recapitulated during the cell
cycle arrest caused by direct inhibition of cyclin-dependent kinases. These studies form a basis for understanding
the normal biology of cellular quiescence.
Citation: Coller HA, Sang L, Roberts JM (2006) A new description of cellular quiescence. PLoS Biol 4(3): e83.
Introduction
Quiescence is the counterpart to proliferation: a reversible,
nondividing state. Although it is a common state for many
somatic cells, including stem cells, we know remarkably little
about the regulation of cellular quiescence. For instance, is
there just one kind of quiescent state, or do cells enter
qualitatively different states depending upon the particular
stimulus that initiated withdrawal from the cell cycle? Is
cellular quiescence static, or is it a dynamic, continually
changing physiological state? Is quiescence essentially a
passive state (i.e., characterized by the absence of factors
needed for cell division), or is it actively maintained?
Answering these questions has been difﬁcult, because a
quiescent cell is more notable for what it doesn’t do (e.g.,
synthesize DNA, generate mitotic spindles) than for having
readily identiﬁable traits of its own. One solution may be to
use patterns of gene expression as a representation of the
unique physiology of nondividing cells. Most of the earlier
studies on ﬁbroblasts have shown that there are substantial
differences in the patterns of expressed genes in quiescent
versus proliferating cells [1–6]. However, these previous
studies did not distinguish gene-expression changes that
were involved in quiescence, per se, from secondary
responses induced by changes in the cellular environment.
To circumvent this problem we used DNA microarrays to ask
whether the same gene-expression changes occur when cells
become quiescent in response to three independent growth-
arrest signals, and for various periods of time. We found that
ﬁbroblast quiescence is a remarkably more dynamic and
diverse collection of states than had been expected, but that it
can also be described by a program of gene expression that is
characteristic of multiple, independent quiescent states. This
program of gene expression reveals the basic biological
attributes of cellular quiescence.
Results
General Approach
Primary human ﬁbroblasts were exposed to mitogen
deprivation, growth at high cell density (‘‘contact inhib-
ition’’), and disruption of cell-substratum adhesions (‘‘loss of
adhesion’’) (Figure 1). Each of these three arrest protocols
caused greater than a 95% decrease in the fraction of cells
undergoing DNA synthesis (Figure 1). DNA microarrays were
used to compare patterns of gene expression in growing cells
and cells arrested for varying periods of time. By comparing
three independent quiescence pathways, we were able to ask
whether there were genes whose expression was associated
with quiescence, per se, rather than with the particular
mechanism of cell-cycle arrest. Our goal was to determine
whether there is a novel set of genes that is associated with
movement into and out of the cell cycle (G1 versus G0
[quiescent] cells) as opposed to the more commonly studied
set of genes that is associated with progression through the
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PLoS BIOLOGYcell cycle (see for instance [7]). We therefore excluded from
our analysis the many genes whose expression is dependent
upon the position of the cell within the cell cycle (e.g., S or M
phase speciﬁc genes) by using a ﬂow cytometer to collect only
those with a 2N (G1) DNA content. Flow cytometry-based
sorting was applied to all samples.
To get an overview of the relationships among the different
quiescent states, we measured the ‘‘genome-wide transcrip-
tional distance’’ between a pair of samples, which was
calculated by summing the differences in expression levels
between the samples for all genes on the microarray [8]. A tree
representing the relationships among cells arrested by differ-
ent methods based on this measure is shown in Figure 2A.
Note that independent, duplicate samples of cells arrested by
each of the three methods are next to each other, demon-
strating that cells arrested by different methods execute
reproducible and signal-speciﬁc gene-expression changes.
We also used two methods to identify speciﬁc genes
regulated in quiescent cells. In the ﬁrst, we ranked the genes
based on their similarity to a stereotyped example of
expression changes, and used permutation tests to determine
the extent of correlation expected by chance. In the second,
we identiﬁed genes regulated 2-fold when cells became
quiescent. The expected number of false positives was
determined by permutation testing. In addition to determin-
ing the number of such genes, we visualized these genes in the
relevant samples with ‘‘heat maps’’ [9] in which low
expression of a gene in a given sample is indicated by green
while high expression is indicated by red.
Quiescence Initiation
Cells were exposed to arrest signals for 14 h, at which time
the fraction undergoing DNA synthesis had decreased 70%–
85%. The relatedness tree (Figure 2A) showed that the
transcriptional proﬁle of each quiescent cell population was
reproducibly distinct from proliferating G1 cells. Thus,
quiescence is not a prolonged pause in G1 but rather is
characterized by distinct gene expression changes. Indeed, a
signiﬁcant number of genes (between 10 and 60) were
uniquely upregulated or downregulated in cells exposed to
each arrest signal for 14 h (Figure 2B and 2C). Some of the
genes regulated by only one or two arrest signals relate to two
central features of quiescent cells—decreased proliferation
and decreased biosynthetic activity. The former include genes
involved in mitogenic signal transduction and in pathways
that directly regulate the cell cycle, and the latter include
genes involved in lipid, nucleotide, and carbohydrate
metabolism (Table 1). We concluded that each signal induced
a unique quiescent state, because these fundamental features
of quiescence (cessation of growth and division) are realized,
at least in part, by different signal-dependent changes in gene
expression. These included upregulated as well as down-
regulated genes, showing that quiescence is an active state.
There was a smaller but statistically signiﬁcant set of genes
that was regulated by all three arrest signals. The upregulated
genes included three transcription factors, ZNF124, HES1,
and RB1, and downregulated genes included the transcrip-
tion factor GABPB2, the mitotic regulator MAD2L1, and
VEGFC. The fact that four pleiotropic transcription factors
were regulated during entry into quiescence suggested that
the cells might induce a generalized program of quiescence
gene expression that would be manifest at later times.
Quiescence Maintenance
We next asked whether the immediate response to arrest
signals, which was characterized largely by signal-speciﬁc
Figure 1. Model System: Growing and Arrested Cells
Photographs of growing cells (A), and cells arrested overnight by loss of
adhesion (B), contact inhibition (C), or mitogen withdrawal (D) are
shown. Growing cells and cells that were arrested for 4 d by one of the
three different arrest signals were incubated with bromodeoxyuridine
(BrdU). Cell nuclei were labeled with an anti-BrdU antibody and
propidium iodide, and analyzed by FACS. DNA content was plotted
along the x-axis, and BrdU intensity was plotted along the y-axis. In
growing cells, 28% of the nuclei incorporated BrdU during a 6-h
incubation, while less than 1% of the arrested cells incorporated BrdU
during the same time period. At 14 h ,10% of the cells were in S phase.
2N (G1) cells in all conditions were purified by sorting.
DOI: 10.1371/journal.pbio.0040083.g001
Figure 2. Quiescence Initiation
(A) Neighbor-joining tree of quiescence initiation. Samples of growing
cells and cells arrested by a single signal for 14 h were flow-sorted.
Transcriptional distances (Affymetrix Genechip suite 4.0.) were deter-
mined for each pairwise comparison among samples as described in
Materials and Methods. A matrix of transcriptional distances was used to
generate a tree depicting the relationship among the growing and
quiescent cells using neighbor-joining methods.
(B) Venn diagrams depicting the number of genes regulated by one, two,
or three arrest signals during quiescence initiation. The number of genes
that were regulated by a single signal, by two out of three signals, or by
all three signals was determined based on either consistent 2-fold
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A New Description of Cellular Quiescenceregulation or ‘‘template-matching.’’ The number of genes expected to be downregulated by a single signal by chance is 7.8, and the number observed
was statistically significant for all three arrest methods (p , 0.001). The number of genes expected to be upregulated by a single signal by chance is 5.1.
The signature for genes upregulated by mitogen withdrawal or contact inhibition alone is significant at p , 0.001, while the signature for genes
upregulated by loss of adhesion is significant at p ¼ 0.004. One gene was expected to be downregulated by two out of three signals by chance. For
mitogen withdrawal combined with contact inhibition, and loss of adhesion combined with contact inhibition, the observed number of downregulated
genes was statistically significantly higher than expectation (p , 0.001). For mitogen withdrawal combined with loss of adhesion, the result was not
statistically significant. The expected number of genes upregulated by two arrest signals is 0.75. For genes upregulated by mitogen withdrawal
combined with contact inhibition, and by loss of adhesion combined with contact inhibition, the number of regulated genes is significant (p , 0.001).
For mitogen withdrawal combined with loss of adhesion, the result was not statistically significant. The number of genes expected to be
downregulated by all three signals was 0.85, and the observation of four was significant at p¼0.009. The number of genes expected to be upregulated
by all three arrest signals is 1.2, and the observation of five is significant at p ¼ 0.006.
(C) ‘‘Heat maps’’ of genes regulated during quiescence initiation. Samples of growing cells and cells arrested by a single signal for 14 h were flow sorted
and analyzed with microarrays. Genes regulated by one, two, or all three signals were identified both by consistent 2-fold change and by ‘‘template-
matching’’ as described in Materials and Methods. Genes are represented by rows; columns indicate samples. The average difference values for each
gene were normalized. The relative expression levels for a gene among the samples are indicated by green for a low value and by red for a high value.
The figure was generated with Java Treeview [54]. The dendrogram above the figure depicts the topology of a neighbor-joining tree generated from
the transcriptional distances between each sample. The complete tree is shown in (A).
DOI: 10.1371/journal.pbio.0040083.g002
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A New Description of Cellular QuiescenceTable 1. Genes Regulated by Specific Arrest Signals
Time Gene Name GO Terms Mitogen
Withdrawal
Contact
Inhibition
Loss of
Adhesion
14 h
UGCG: UDP-glucose ceramide glucosyltransferase Lipid metabolism m
GDF5: growth differentiation factor 5 Growth, cell communication, signal transduction m
IGFBP3: IGF binding protein 3 Regulation of growth, signal transduction,
cell communication
m
HMGCL: 3-hydroxymethyl-3-methylglutaryl-Co A lyase Amino acid metabolism m
ALDH2: aldehyde dehydrogenase 2
family (mitochondrial)
Carbohydrate metabolism m
JARID2: Jumonji, AT rich interactive domain 2 Regulation of transcription m
PPP2R5A: protein phosphatase 2,
regulatory subunit B
Cell communication, signal transduction m
PASK: PAS domain containing
serine/threonine kinase
Cell communication, signal transduction m
SLC20A2: solute carrier (phosphate transporter) Establishment of localization, transport mm
RGS2: regulator of G-protein signalling 2, 24kDa Cell cycle, cell communication, signal transduction .
CDK10: cyclin-dependent kinase (CDC2-like) 10 No swiss prot identifiers .
MAP3K5: mitogen-activated protein
kinase kinase kinase 5
Cell communication, signal transduction .
ITPKA: inositol 1,4,5-trisphosphate 3-kinase A Cell communication, signal transduction .
PL6: placental protein 6 Cell communication, signal transduction .
NR4A1: nuclear receptor subfamily 4,
group A, member 1
Cell communication, signal transduction,
regulation of transcription
.
NR4A2: nuclear receptor subfamily 4,
group A, member 2
Cell communication, signal transduction,
regulation of transcription
.
CUL2: cullin 2 Cell cycle, negative regulation of cell proliferation .
CENPA: centromere protein A, 17kDa Chromosome organization and biogenesis .
LMNB1: lamin B1 No swiss prot identifiers .
LBR: lamin B receptor No swiss prot identifiers .
FER: fer (fps/fes related) tyrosine kinase No swiss prot identifiers .
DHX9: DEAH (Asp-Glu-Ala-His) box polypeptide 9 No swiss prot identifiers .
FASN: fatty acid synthase No swiss prot identifiers .
PRPS1: phosphoribosyl pyrophosphate synthetase 1 Nucleotide metabolism .
UMPS: uridine monophosphate synthetase Nucleotide metabolism .
FNTB: farnesyltransferase, CAAX box, beta Protein metabolism .
MRPL12: mitochondrial ribosomal protein L12 Protein metabolism .
KPNA3: karyopherin alpha 3 (importin alpha 4) Establishment of localization, protein transport .
PCNA: proliferating cell nuclear antigen Regulation of cell cycle, cell proliferation,
regulation of DNA replication
.
METTL1: methyltransferase-like 1 RNA metabolism .
SFPQ: splicing factor proline/glutamine rich RNA metabolism .
SFRS2: splicing factor, arginine/serine-rich 2 RNA metabolism .
SF3A1: splicing factor 3a, subunit 1, 120kDa RNA metabolism .
DDX39: DEAD (Asp-Glu-Ala-Asp) box
polypeptide 39
RNA metabolism .
BOP1: block of proliferation 1 RNA metabolism, ribosomal biogenesis .
INPP5A: inositol polyphosphate-5-phosphatase Cell communication .
ARG2: arginase, type II Amino acid metabolism .
CUL1: cullin 1 Cell cycle, regulation of cell proliferation .
PRKCM: protein kinase C, mu Cell proliferation, cell communication,
signal transduction
.
KIAA0092: translokin Cell communication, signal transduction,
intracellular transport
.
PCYT2: phosphate cytidylyltransferase 2,
ethanolamine
Lipid metabolism .
PRKAR1B: protein kinase, cAMP-dependent,
regulatory
Nothing listed .
HIST2H4: histone 2, H4 No swiss prot identifiers .
MAP2K5: mitogen activated protein
kinase kinase 5
Protein metabolism .
FGF4: fibroblast growth factor 4 Reglation of cell cycle, cell proliferation,
signal transduction
.
CCNE1: cyclin E1 Regulation of cell cycle, cell division .
CREBL1: cAMP responsive element
binding protein-like 1
Cell communication, signal transduction,
regulation of transcription
.
ADORA2B: adenosine A2b receptor Cell communication, signal transduction,
response to external stimulus
.
NP: nucleoside phosphorylase Nucleobase, nucleoside, nucleotide,
and nucleic acid metabolism
..
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Time Gene Name GO Terms Mitogen
Withdrawal
Contact
Inhibition
Loss of
Adhesion
MRPL19: mitochondrial ribosomal protein L19 Protein metabolism ..
MPHOSPH6: M-phase phosphoprotein 6 Regulation of cell cycle ..
ETFDH: electron-transferring-flavoprotein
dehydrogenase
Generation of precursor metabolites and energy ..
ASL: argininosuccinate lyase Amino acid metabolism ..
SLC1A4: solute carrier (amino acid transporter) Establishment of localization, amino acid transport ..
UMPK: uridine monophosphate kinase Biosynthesis ..
LPIN1: lipin 1 Cell differentiation ..
MVD: mevalonate (diphospho) decarboxylase Lipid metabolism ..
IDI1: isopentenyl-diphosphate delta isomerase Lipid metabolism ..
SCAP: SREBP cleavage-activating protein Lipid metabolism ..
FGF5: Fibroblast growth factor 5 Regulation of cell cycle, cell proliferation,
cell communication
..
SLC12A4: solute carrier (ion transporter) Regulation of cell cycle ..
SNRPC: small nuclear ribonucleoprotein polypeptide C RNA metabolism ..
4d
ASNS: asparagine synthetase Amino acid metabolism m
ATP6V1A: ATPase, Hþ transporting, lysosomal Generation of precursor metabolites and energy m
UGCG: UDP-glucose ceramide glucosyltransferase Lipid metabolism m
ARHGEF12: Rho guanine exchange factor (GEF) 12 No swiss prot identifiers m
CALML3: calmodulin-like 3 No swiss prot identifiers m
DDX3X: DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 No swiss prot identifiers m
NT5C2: 59-nucleotidase, cytosolic II No swiss prot identifiers m
CACNA1E: calcium channel, voltage-dependent No swiss prot identifiers m
CCNG2: cyclin G2 Regulation of cell cycle, cell division m
TGFB2: transforming growth factor, beta 2 Regulation of cell cycle, cell proliferation, cell growth m
TGFB3: transforming growth factor, beta 3 Regulation of cell cycle, cell proliferation,
cell growth, cell communication
m
GNAI1: Guanine binding protein,
alpha inhibiting activity
Cell communication, signal transduction m
GNAQ: guanine binding protein, q polypeptide Cell communication, signal transduction m
E2F4: E2F transcription factor 4, p107/p130-binding Regulation of cell cycle, regulation of transcription m
DUSP4: dual specificity phosphatase 4 Regulation of cell cycle, cell communication,
signal transduction
m
DUSP5: dual specificity phosphatase 5 Protein metabolism m
HARS: histidyl-tRNA synthetase Amino acid metabolism .
GK: Glycerol kinase Nothing listed .
POLD2: polymerase (DNA directed)
regulatory subunit
DNA replication .
KCNAB1: potassium voltage-gated channel Establishment of localization, ion transport .
TOMM34: translocase of outer
mitochondrial membrane
Establishment of protein localization,
intracellular transport
.
SEC23B: Sec23 homolog B Protein localization, intracellular transport .
HADH2: hydroxyacyl-Coenzyme A dehydrogenase Lipid metabolism .
POLR2I: polymerase (RNA) II (DNA directed) No swiss prot identifiers .
PDXK: pyridoxal (pyridoxine, vitamin B6) kinase No swiss prot identifiers .
PMPCA: peptidase (mitochondrial processing) alpha Protein metabolism, protein catabolism .
DDX39: DEAD (Asp-Glu-Ala-Asp) box polypeptide 39 RNA metabolism .
SLC20A1: solute carrier (phosphate transporter) Cell communication, signal transduction,
establishment of localization
.
EIF3S9: eukaryotic translation initiation factor 3 Protein metabolism .
TNFRSF17: tumor necrosis factor receptor superfamily Cell proliferation, signal transduction .
GUCY1A2: guanylate cyclase 1, soluble, alpha 2 Cell communication, signal transduction .
IDH1: isocitrate dehydrogenase 1 (NADPþ), soluble Carbohydrate metabolism .
SLC25A1: solute carrier (citrate transporter) Carbohydrate metabolism .
KCNMA1: potassium large conductance channel Cell communication, establishment of localization,
ion transport
.
LPIN1: lipin 1 Cell differentiation .
FGF5: fibroblast growth factor 5 Regulation of cell cycle, cell proliferation,
cell communication
.
MAT2A: methionine adenosyltransferase II, alpha Cellular metabolism .
SLC25A4: solute carrier (adenine translocator) Generation of precursor metabolites and energy .
ATP1B1: ATPase, Naþ/Kþ transporting Establishment of localization, ion transport .
LDLR: low density lipoprotein receptor Lipid metabolism .
FDPS: farnesyl diphosphate synthase Lipid metabolism .
SREBF1: sterol regulatory element binding tx factor 1 Regulation of transcription, lipid metabolism .
SREBF2: sterol regulatory element binding tx factor 2 Regulation of transcription, lipid metabolism .
RRAS2: Related RAS viral (r-ras) oncogene homolog 2 No swiss prot identifiers .
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A New Description of Cellular Quiescencechanges, foreshadowed mostly signal-speciﬁc expression
changes at a later time point. Alternatively, did these short-
term largely divergent states ultimately coalesce into a
common quiescent state? After 4 d, there were many more
expression changes than after an overnight arrest, and the
transcriptional distance to each state increased on average
3.3-fold (Figure 3A). Moreover, each arrest state maintained
its unique character. There continued to be strong signatures
for genes that were regulated speciﬁcally by a single arrest
signal (Figure 3B and 3C), and many of these genes were
regulators of cell growth and cell division (Table 1).
We wanted to ascertain whether these quiescence state-
speciﬁc expression changes reﬂect bonaﬁde differences in the
gene expression pattern in response to different signals, or
whether they might reﬂect only a difference in the kinetics of
the induction of a similar response induced by different
signals. We discovered that much of the signal-speciﬁc
signature observed after 14 h persisted through 4 d (Figure
S1). This makes it unlikely that differences reﬂect simply
timeshifting of a common signature. We also discovered a
surprisingly strong signature for genes upregulated by
mitogen withdrawal and downregulated by loss of adhesion,
or vice versa, at both quiescence initiation and quiescence
maintenance (Figure S2). For these reasons, we concluded
that the gene expression changes observed most likely reﬂect
qualitatively different quiescent states and do not represent
the same gene expression changes induced by different
signals with different kinetics.
Superimposed on this signal-speciﬁc pattern, however, was
also a convergence of gene expression changes. After 4 d of
arrest, 35 genes were downregulated and 96 were upregulated
by all three signals (Figure 3B and 3C). These results suggested
that there might be a ﬁbroblast ‘‘quiescence program,’’ a set
of gene-expression changes central to any long-term quies-
cent state and independent of the speciﬁc arrest signal
(Figure 4).
Definition of a Quiescence Program, and Its Expression
during Prolonged Arrest
There were many gene-expression changes that were
shared by cells reaching a longer transcriptional distance
from growing cells—those arrested by an individual signal for
4 d and those grown to conﬂuence and maintained for 4 d or
20 d (see below). We deﬁned a ‘‘quiescence program’’ (see
Materials and Methods) by identifying genes consistently
regulated in these deeper arrests. There were 116 upregulated
and 33 downregulated genes that met these criteria, while the
expectation due to random chance was approximately 1
(Table 2). The quiescence program included not only genes
involved in regulating cell growth and division, but also genes
that suppressed apoptosis, suppressed differentiation, and
were involved in intercellular communication; all of these are
likely to be essential to maintaining cells and tissues in a
reversible, viable arrested state (see Discussion).
Previous studies had shown that cells deprived of serum for
weeks rather than days took longer to reenter the cell cycle
[10,11]. At the molecular level this might be manifest as an
even greater change in the expression of those genes that had
been regulated during shorter arrests. We allowed the cells to
grow to conﬂuence and then maintained them in an arrested
state with regular medium changes for approximately 20 d.
We compared them with cells arrested by the same protocol
for only 4 d. Prolonged quiescence resulted in the longest
transcriptional distance from growing cells of any arrested
state (Figure 5A). There was a 50% increase in the transcrip-
tional distance to growing cells in cells arrested by growth to
conﬂuence for 20 d versus 4 d. Notably, 82% (27/33) of the
downregulated genes and 77% (89/116) of the upregulated
genes in the quiescence program were repressed or induced
more strongly at 20 d of quiescence than at 4 d (Figure 5B–
5D). Thus, arrest for longer periods of time, which results in a
‘‘deepening’’ of the quiescent state, is associated with an
exaggeration of the quiescence program (Figure 4).
Prolonged arrest by growth to conﬂuence also resulted in a
Table 1. Continued
Time Gene Name GO Terms Mitogen
Withdrawal
Contact
Inhibition
Loss of
Adhesion
FASN: fatty acid synthase No swiss prot identifiers .
GTF2F2: general transcription factor IIF, polypeptide 2 Regulation of transcription .
UBTF: upstream binding transcription factor Regulation of transcription .
ADCY7: adenylate cyclase 7 Cell communication, signal transduction .
EDG2: endothelial differentiation Cell communication, signal transduction .
UMPK: uridine monophosphate kinase Metabolism ..
PFKFB3: 6-phosphofructo-2-kinase Carbohydrate metabolism ..
FABP5: fatty acid binding protein 5 Lipid metabolism ..
PAICS: phosphoribosylaminoimidazole carboxylase Nucleotide metabolism ..
MCM5: MCM5 minichromosome maintenance deficient 5 Regulation of cell cycle, DNA replication,
regulation of transcription
..
MVD: mevalonate (diphospho) decarboxylase Lipid metabolism ..
TTK: TTK protein kinase No swiss prot identifiers ..
A subset of genes regulated by one or two arrest signals after 14 h or 4 d are listed along with the direction of change and the arrest conditions in which they are regulated.
Functional categories represent Gene Ontology terms previously assigned to the particular gene. To assign these categories, the Affymetrix-provided Swissprot identifier (http://www.affymetrix.com/support/index.affx) was determined. Using
GO::Termfinder modules [55] to read in the latest (June 2005) versions of the GO biological process aspect and the GOA-provided Annotations [56], we identified all unique ancestors within the GO tree. A few informative biological process
terms are listed.
m, upregulated; ., downregulated.
DOI: 10.1371/journal.pbio.0040083.t001
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(A) Neighbor-joining tree of quiescence initiation and maintenance. Neighbor-joining tree of the transcriptional distance between samples after
overnight and 4 d of quiescence generated as described in Figure 2A.
(B) Venn diagrams depicting the number of genes regulated by one, two, or three arrest signals during quiescence maintenance. Methods are as
described in (Figure 2B), except that cells were arrested for 4 d. The number of genes downregulated specifically by mitogen withdrawal or by loss of
adhesion was significantly greater than the expectation (7.8 genes) at p , 0.001. The number of genes downregulated by contact inhibition was not
statistically significant. The expected number of genes upregulated by a single signal was 5.1, and the signature for genes upregulated by each of the
signals individually was statistically significant (p , 0.001). The expected number of genes downregulated by two signals was one, and the observed
values for all three combinations were significant at p , 0.001. The expected number of genes downregulated by all three arrest signals was 0.85, and
the observed value of 33 was highly significant (p , 0.001). All combinations of upregulation by two signals were statistically significantly elevated (p ,
0.001) as compared with the expectation of 0.75 genes. The number of genes expected to be upregulated by all three signals was 1.2, and the observed
value of 96 was significantly different (p , 0.001).
(C) ‘‘Heat maps’’ of genes regulated during quiescence maintenance. ‘‘Heat map’’ of the genes regulated after 4 d of quiescence and dendrogram are
as described in Figure 2C.
DOI: 10.1371/journal.pbio.0040083.g003
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A New Description of Cellular Quiescencesignal-speciﬁc gene expression proﬁle in addition to an
enhancement of the quiescence program. We identiﬁed 26
upregulated and 87 downregulated genes that were consis-
tently regulated in cells grown to conﬂuence for 20 d but not
by mitogen withdrawal, contact inhibition, or loss of adhesion
for 4 d (Figure 5E and Table 3).
Combination of Arrest Signals; Rapid Onset of Quiescence
Fibroblasts are most effectively made quiescent by expos-
ing them to combinations of arrest signals. We hypothesized
that a molecular explanation might involve activation of the
quiescence program. To test this, we arrested cells for 14 h by
withdrawing mitogens and simultaneously either plating
them at high density or arresting them by loss of adhesion.
Manipulating two pathways together had a synergistic effect;
cells arrested by either combination were even farther from
growing cells than the sum of the distances to the individual
arrest states (Figure 6A and 6B).
The fraction of upregulated quiescence program genes that
were also 2-fold upregulated in cells arrested overnight by a
single signal was small—5% for mitogen withdrawal, 9% for
contact inhibition, and 3% for loss of adhesion. In contrast, a
much higher fraction of the upregulated quiescence program
genes were regulated in cells arrested overnight by a
combination of signals—32% for mitogen withdrawal plus
contact inhibition, and 43% for mitogen withdrawal plus loss
of adhesion (Figure 6C). Therefore, combining arrest signals
shortcircuited the pathway to cellular quiescence, resulting in
a more rapid expression of the quiescence program (Figure 4).
Cell-Cycle Arrest by Overexpression of Cyclin-Dependent
Kinase Inhibitors
The observed induction of quiescence program genes
might have been a consequence of cell-cycle arrest. For
instance, different arrest signals might all directly down-
regulate cell-cycle proteins, and expression of quiescence
program genes would then be a downstream, secondary
effect. Alternatively, expression of the quiescence program
could be the primary event that is induced in common by
each of the extracellular anti-proliferative signals. Cell-cycle
arrest would be one downstream effect of the quiescence
program, being induced by a subset of the quiescence
program genes.
To distinguish between these models, we bypassed extrac-
ellular signal transduction pathways, and directly arrested the
cell cycle by inhibition of cyclin-dependent kinases (CDKs).
The ﬁrst model predicts that cell-cycle arrest should be
sufﬁcient to induce the quiescence program, while the second
predicts that it would not. We used retroviral-mediated gene
transduction to ectopically overexpress the CDK inhibitors
(CKI) p21 or p27. This efﬁciently blocked cell proliferation,
and did not induce cellular senescence as monitored by
expressionofsenescence-associated b-galactosidase(Figure7).
Cells arrested by CKI overexpression formed a clade that
was distinct from the clade comprised of cells arrested by
extracellular signals (Figure 8A). The transcriptional pattern
induced by CKI overexpression did not closely resemble the
quiescent state induced by any particular extracellular signal.
Only a small proportion of all of the genes regulated by all
signals or an individual signal were also regulated by CKIs,
with the greatest overlap among genes downregulated by all
signals (Figure 8B–8E). Indeed, although downregulated
quiescence program genes were likely also to be down-
regulated by CDK inhibition, many upregulated genes in the
quiescence program were not induced by CDK inhibition.
More precisely, genes regulated by four different anti-
proliferative signals were extremely likely (78%) to be
regulated in a ﬁfth condition. Among genes that were
consistently downregulated 2-fold in all of the quiescent
states, a signiﬁcant fraction (54%) was also downregulated in
cells arrested by p21 and p27 (Table 3). These commonly
regulated genes clustered into the functional category of cell-
cycle regulators. Thus, there was a self-reinforcing compo-
nent to cell-cycle arrest, in the sense that CDK inhibition
caused downregulation of additional genes that also directly
affected the cell cycle.
Figure 4. Summary of the Relationships among Quiescent States
In cells arrested overnight by a specific arrest signal, gene expression changes are largely signal-specific with a small amount of overlap. When cells have
been arrested for 4 d, there continue to be signal-specific changes, but now there are a large number of commonly regulated genes that we refer to as
a ‘‘quiescence program.’’ In cells arrested for 20 d, the intensity of the changes in the quiescence program are magnified. The three circles are intended
to reflect the enhancement of the quiescence program at 20 d. We have not analyzed all the three arrest conditions at this late time point. When cells
are arrested by a combination of extracellular signals, quiescence program gene expression changes appear after only an overnight arrest.
DOI: 10.1371/journal.pbio.0040083.g004
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A New Description of Cellular QuiescenceTable 2. Genes in the Quiescence Program
Upregulated or
Downregulated
Gene Name GO Term
Upregulated PEPD: peptidase D Amino acid metabolism
DOC1: downregulated in ovarian cancer 1 Biological process unknown
HYAL2: hyaluronoglucosaminidase 2 Carbohydrate metabolism
GLB1: galactosidase, beta 1 Carbohydrate metabolism
NAGLU: N-acetylglucosaminidase Carbohydrate metabolism
TIMP3: tissue inhibitor of metalloproteinase 3 Cell communication
CDH11: cadherin 11, type 2 Cell communication, cell adhesion
VCAM1: vascular cell adhesion molecule 1 Cell communication, cell adhesion
LAMC1: laminin, gamma 1 (formerly LAMB2) Cell communication, cell adhesion
CTNNA1: catenin (cadherin-associated protein), alpha 1, 102kDa Cell communication, cell adhesion
TNC: tenascin C (hexabrachion) Cell communication, cell adhesion
FAT: FAT tumor suppressor homolog 1 Cell communication, cell adhesion
PLEKHC1: pleckstrin homology domain containing, family C Cell communication, cell adhesion, cytoskeleton
organization, and biogenesis
FGD1: Faciogenital dysplasia Cell communication, cytoskeleton organization, and biogenesis
BRE: brain and reproductive organ-expressed (TNFRSF1A modulator) Cell communication, signal transduction
TNFRSF1A: tumor necrosis factor receptor superfamily, member 1A Cell communication, signal transduction
ROR1: receptor tyrosine kinase-like orphan receptor 1 Cell communication, signal transduction
PRDX4: peroxiredoxin 4 Cell communication, signal transduction
PTPRG: protein tyrosine phosphatase, receptor type, G Cell communication, signal transduction
GPR37: G protein-coupled receptor 37
a Cell communication, signal transduction
TIP-1: Tax interaction protein 1 Cell communication, signal transduction
CHN1: Chimerin (chimaerin) 1 Cell communication, signal transduction
MAPK7: mitogen-activated protein kinase 7 Cell communication, signal transduction
AGT: angiotensinogen (serine (or cysteine) proteinase inhibitor) Cell communication, signal transduction
FGFR1: fibroblast growth factor receptor 1 Cell communication, signal transduction
APP: amyloid beta (A4) precursor protein Cell communication, signal transduction, cell adhesion
PTK7: PTK7 protein tyrosine kinase 7 Cell communication, signal transduction, cell adhesion
LIMK1: LIM domain kinase 1 Cell communication, signal transduction,
cytoskeleton organization and biogenesis
IL1R1: interleukin 1 receptor, type I Cell communication, signal transduction, immune response
IL6: interleukin 6 Cell communication, signal transduction, immune response
BDKRB2: bradykinin receptor B2
a Cell communication, signal transduction, immune response
AP3S1: adaptor-related protein complex 3, sigma 1 subunit Cell communication, signal transduction, intracellular transport
ITPR1: inositol 1,4,5-triphosphate receptor, type 1 Cell communication, signal transduction, metal ion transport
CPE: carboxypeptidase E Cell communication, signal transduction, protein catabalism
MADH1: MAD, mothers against decapentaplegic homolog 1 Cell communication, signal transduction, regulation of transcription
SEPT6: septin 6
a Cell cycle, cell division
MYH10: myosin, heavy polypeptide 10, non-muscle Cell division
SERPINF1: serine proteinase inhibitor pigment epithelium derived factor Cell proliferation
ERBB2: v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 Cell proliferation, cell communication,
signal transduction
LRP1: low density lipoprotein-related protein 1 Cell proliferation, lipid metabolism
A2M: alpha-2-macroglobulin Cellular metabolism, establishment of localization,
intracellular transport
PTGDS: prostaglandin D2 synthase 21kDa Cellular metabolism, lipid metabolism
TFRC: transferrin receptor (p90, CD71) Cellular metabolism, metal ion transport
CTSO: cathepsin O Cellular metabolism, protein catabalism
PPP2CB: protein phosphatase 2 (formerly 2A) Cellular protein metabolism
PTPRK: Protein tyrosine phosphatase, receptor type, K Cellular protein metabolism
NMT1: N-myristoyltransferase 1 Cellular protein metabolism
CDR2: cerebellar degeneration-related protein 2 Cellular protein metabolism
HERC1: Hect (homologous to E6-AP and RCC1-like domain) Cellular protein metabolism
UROS: uroporphyrinogen III synthase Cofactor metabolism
TPM1: tropomyosin 1 (alpha) Development
COL3A1: collagen, type III, alpha 1 Development, establishment of localization, transport
ACTA2: actin, alpha 2, smooth muscle, aorta Development, morphogenesis
MGP: matrix Gla protein
a Development, morphogenesis, response to
external stimulus
TNFAIP1: tumor necrosis factor, alpha-induced protein 1
a Establishment of localization, transport
COL4A5: collagen, type IV, alpha 5 Establishment of localization, transport
LUM: lumican Extracellular matrix organization and biogenesis
PROS1: protein S (alpha) Homeostasis, response to external stimulus
HLA-E: major histocompatibility complex, class I, E
a Immune response
PCCA: propionyl Coenzyme A carboxylase, alpha polypeptide Lipid metabolism
ECH1: Enoyl Coenzyme A hydratase 1, peroxisomal Lipid metabolism
GM2A: GM2 ganglioside activator protein Lipid metabolism
AFAP: actin filament associated protein No swiss prot identifiers
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Upregulated or
Downregulated
Gene Name GO Term
RBMS1: RNA binding motif, single stranded interacting protein 1 No swiss prot identifiers
NR2F1: nuclear receptor subfamily 2, group F, member 1 No swiss prot identifiers
HIC1: hypermethylated in cancer 1 No swiss prot identifiers
PL1: endogenous retrovirus envelope region mRNA (PL1) No swiss prot identifiers
CEBPD: CCAAT/enhancer binding protein (C/EBP), delta No swiss prot identifiers
LAMP2: lysosomal-associated membrane protein 2 No swiss prot identifiers
NNMT: Nicotinamide N-methyltransferase No swiss prot identifiers
SAT: Spermidine/spermine N1-acetyltransferase No swiss prot identifiers
RRAGA: Ras-related GTP binding A No swiss prot identifiers
SPHAR: S-phase response (cyclin-related) No swiss prot identifiers
OBRGRP: leptin receptor gene-related protein
a No swiss prot identifiers
PIK3C3: phosphoinositide-3-kinase, class 3 No swiss prot identifiers
ITGA1: integrin, alpha 1 No swiss prot identifiers
STOM: stomatin No swiss prot identifiers
MUC1: mucin 1, transmembrane Nothing listed
TGFBR2: transforming growth factor, beta receptor II
a Nothing listed
GARP: glycoprotein A repetitions predominant Nothing listed
AMPD3: adenosine monophosphate deaminase (isoform E) Nucleotide metabolism
ABCD3: ATP-binding cassette, sub-family D (ALD) Organelle organization and biogenesis
PEX19: peroxisomal biogenesis factor 19 Organelle organization and biogenesis
SOD3: superoxide dismutase 3, extracellular Oxygen and reactive oxygen species metabolism
BMP1: bone morphogenetic protein 1, (pro collagen C proteinase) Protein catabolism
SPG7: spastic paraplegia 7, paraplegin Protein catabolism
PLAT: plasminogen activator, tissue Protein catabolism, response to external stimulus
PAM: peptidylglycine alpha-amidating monooxygenase Protein metabolism
TRB2: tribbles homolog 2 Protein metabolism
MYLK: myosin, light polypeptide kinase Protein metabolism
IFITM1: Interferon induced transmembrane protein 1 (9–27) Regulation of cell cycle, cell communication
STAT1: signal transducer and activator of transcription 1, 91kDa Regulation of cell cycle, cell communication,
regulation of transcription
TCF7L2: transcription factor 7-like 2 (TCF-4)
a Regulation of cell cycle, cell communication,
regulation of transcription
CCND2: cyclin D2 Regulation of cell cycle, cell division
TP53: tumor protein p53 (Li-Fraumeni syndrome) Regulation of cell cycle, regulation of transcription
GPNMB: glycoprotein (transmembrane) nmb Regulation of cell proliferation
BCL6: B-cell CLL/lymphoma 6 (zinc finger protein 51) Regulation of cell proliferation, regulation of transcription
IGBP1: immunoglobulin (CD79A) binding protein 1 Regulation of signal transduction
MXI1: MAX interacting protein 1
a Regulation of transcription
ATBF1: AT-binding transcription factor 1 Regulation of transcription
ZNF143: zinc finger protein 143 Regulation of transcription
TRIM22: tripartite motif-containing 22 Regulation of transcription
PIPPIN: RNA-binding protein pippin Regulation of transcription, RNA metabolism
SERPING1: serine (or cysteine) proteinase inhibitor Response to external stimulus, immune response
F3: coagulation factor III (thromboplastin, tissue factor)
a Response to external stimulus, immune response
MX2: myxovirus (influenza virus) resistance 2
a Response to external stimulus, immune response
CFHL1: complement factor H-related 1 Response to external stimulus, immune response
FCGRT: Fc fragment of IgG, receptor, transporter, alpha Response to external stimulus, immune response
C1R: complement component 1, r subcomponent Response to external stimulus, immune response
C1S: complement component 1, s subcomponent Response to external stimulus, immune response
ADAR: adenosine deaminase, RNA-specific RNA metabolism
STK25: serine/threonine kinase 25 (STE20 homolog, yeast) Signal transduction
NFKB2: nuclear factor of kappa light polypeptide gene enhancer Signal transduction, regulation of transcription
CRBP: cellular retinol binding protein Vitamin metabolism
RBP1: retinol binding protein 1, cellular Vitamin metabolism, establishment of localization
EPHX1: epoxide hydrolase 1, microsomal (xenobiotic) Xenobiotic metabolism, response to external stimulus
Downregulated GGH: gamma-glutamyl hydrolase
a Amino acid metabolism
DLG7: discs, large homolog 7 (Drosophila)
a Cell communication
HIST1H4C: histone 1, H4c Cell communication, chromosome
organization, and biogenesis
NPTX1: neuronal pentraxin I Cell communication, establishment of localization
GNAT1: guanine nucleotide binding protein (G protein) Cell communication, signal transduction
OPRK1: opioid receptor, kappa 1 Cell communication, signal transduction
STMN1: stathmin 1/oncoprotein 18 Cell communication, signal transduction
PLCB4: phospholipase C, beta 4 Cell communication, signal transduction,
lipid metabolism
CDKN3: cyclin-dependent kinase inhibitor 3
a Cell cycle arrest, cell cycle, regulation of cell proliferation
CUL1: cullin 1 Cell cycle arrest, negative regulation of cell proliferation,
cell cycle
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A New Description of Cellular QuiescenceIn contrast, only 12% of the quiescence program genes that
were upregulated 2-fold in all arrest conditions were also
upregulated by CKI overexpression, and these genes did not
fall into any particular functional class (Table 2). Therefore, a
single molecule that causes cell-cycle arrest could not
recapitulate the complete, functionally diverse quiescence
program.
Quiescent Cells, but Not Cell Cycle Arrested Cells, Are
Resistant to Differentiation
Reversibility is the deﬁning characteristic that distinguishes
quiescence from other nondividing cell states. Based on our
gene expression results, we hypothesized that quiescent cells
remain in this reversible state by activating pathways that
prevent the inappropriate adoption of nondividing states
associated with irreversible cell-cycle arrest, such as senes-
cence and terminal differentiation. To test this hypothesis, we
asked whether quiescent ﬁbroblasts were resistant to terminal
differentiation. We transduced human dermal ﬁbroblasts
(strain 91-SF5) with a retroviral vector expressing a MyoD-
estrogen receptor fusion protein [12] and subsequently
treated the cells with b-estradiol (10
 7 M) to activate MyoD
and induce the program of gene expression that results in
myogenic differentiation [13], (see Materials and Methods for
details). Muscle differentiation was monitored by real-time
RT-PCR for expression of the myogenesis markers myogenin
and myosin heavy chain. As can be seen in Figure 9, activation
of MyoD in proliferating cells dramatically induced myogenin
(Figure 9A) and myosin heavy-chain expression (Figure 9D),
whereas ﬁbroblasts that were made quiescent for 4 d by either
serum withdrawal (Figure 9A and 9D) or contact inhibition
(Figure 9B and 9E) were resistant to differentiation, as
evidenced by an approximately 10-fold decrease in both
myogenin and myosin heavy-chain expression levels. Quies-
cence did not affect MyoD-ER expression (unpublished data).
Our results had indicated that direct inhibition of CDKs
arrested the cell cycle, but did not induce the quiescence
program of gene expression. We therefore hypothesized that
CKI-arrested cells would not share the same functional
properties as naturally quiescent cells. Speciﬁcally, CDK
inhibition did not induce the expression of genes that were
associated with inhibition of differentiation (see Discussion),
and we therefore tested their ability to undergo MyoD-
induced myogenic differentiation. Fibroblasts expressing the
MyoD-ER fusion were transduced with a retroviral vector
expressing the CKI p21
Cip1, or with an empty vector as a
control. The p21 expressing cells stopped proliferating,
whereas the control cells did not (unpublished data). After
3 d, cells were induced to differentiate by exposure to b-
estradiol. As shown in Figure 9C and 9F, nonproliferating
cells transduced with the CKI p21 and control cells expressed
similar amounts of myogenin and myosin heavy chain. Thus,
the cell-cycle arrest induced by p21 was compatible with
myogenesis, which was in contrast to the differentiation
resistance exhibited by ﬁbroblasts that were quiescent due to
contact inhibition or growth-factor deprivation. This sup-
Table 2. Continued
Upregulated or
Downregulated
Gene Name GO Term
RCC1: chromosome condensation 1 Cell cycle, cell division
CKS2: CDC28 protein kinase regulatory subunit 2
a Cell cycle, cell proliferation, signal transduction,
cell communication
CNAP1: chromosome condensation-related SMC-associated protein 1
a Cell division, cell cycle
UBE2S: ubiquitin-conjugating enzyme E2S
a Cellular protein metabolism
CENPA: centromere protein A, 17kDa
a Chromosome organization and biogenesis
TK1: thymidine kinase 1, soluble
a DNA replication, nucleobase, nucleoside, nucleotide,
and nucleic acid metabolism
TYMS: thymidylate synthetase
a DNA replication, nucleobase, nucleoside, nucleotide,
and nucleic acid metabolism
DBI: diazepam binding inhibitor (acyl-Coenzyme A binding protein)
a Establishment of localization, transport
NAPG: N-ethylmaleimide–sensitive factor attachment protein Establishment of protein localization, transport
KIAA0101: KIAA0101 gene product
a No swiss prot identifiers
LMNB1: lamin B1
a No swiss prot identifiers
TMPO: thymopoietin
a No swiss prot identifiers
HAS2: hyaluronan synthase 2 No swiss prot identifiers
HNRPM: heterogeneous nuclear ribonucleoprotein M No swiss prot identifiers
KIAA0114: KIAA0114 gene product No swiss prot identifiers
PSME4: proteasome (prosome, macropain) activator subunit 4 No swiss prot identifiers
S100A4: S100 calcium binding protein A4 No swiss prot identifiers
PPN: porcupine
a Nothing listed
USP14: ubiquitin specific protease 14
a Protein catabolism
MRPL23: mitochondrial ribosomal protein L23 Protein metabolism, protein biosynthesis
CDC20: CDC20 cell division cycle 20 homolog
a Regulation of cell cycle, cell division
CCNB1: cyclin B1
a Regulation of cell cycle, cell division, mitosis
FOXM1: forkhead box M1
a Regulation of transcription
Genes consistently regulated by multiple arrest signals were defined as described in the text. Functional category information was assigned as described in Table 1.
Genes indicated in boldface are regulated even further in cells arrested by growth to confluence for 20 d as compared with 4 d.
aGenes also regulated in models of T cell activation.
DOI: 10.1371/journal.pbio.0040083.t002
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A New Description of Cellular Quiescenceports our conclusion that the quiescence program of gene
expression, which is induced in cells that become quiescent in
response to external signals but not by direct CDK inhibition,
ensures the reversibility of the quiescent state by inhibiting
terminal differentiation.
Discussion
The conceptually important points that emerge from our
work are: 1) that quiescence is not a unique state but rather a
collection of states that are determined by the initiating
signal; 2) that it is possible to identify genes that are
universally characteristic of quiescence (i.e., signal independ-
ent) implying the existence of a genetic program of
quiescence; and 3) that quiescence is functionally different
from cell-cycle arrest.
Quiescence Is Not a Unique State
Our ﬁrst major observation was that different quiescence
signals arrested growth and division by different mechanisms,
and on this basis we concluded that cells enter different
signal-dependent quiescent ‘‘states.’’ The unique features of
these different quiescent states were evident both in the
pathways by which cells exited the cell cycle in response to
antimitogenic signals, as well as in the pathways by which
growth and proliferation were suppressed after the cells had
entered the nondividing states. More speciﬁcally, we observed
that different antiproliferative signals initiated cell-cycle exit
by affecting the expression of different growth regulatory
genes (Table 1). For example, contact inhibition resulted in
downregulation of cul-2, PCNA, lamin B and its receptor,
CENPA, biosynthetic enzymes in nucleotide metabolism,
splicing factors, and different members of the inositol
triphosphate signaling pathway. Loss of adhesion caused
downregulation of cyclin E1, Cul-1, a protein kinase C isoform,
another MAP kinase, and FGF4. Mitogen withdrawal caused
the downregulation of G-protein–signaling molecules, and
kinases from the MAP kinase and inositol-triphosphate–
signaling pathways, as well as upregulation of IGFBP3. The
importance of all of these proteins for controlling cell
proliferation has been established, but their unique relation-
ships to speciﬁc quiescence signals were not known. We do
not mean to imply that the altered expression of any one
gene alone would be sufﬁcient to explain the mechanism of
cell cycle exit in response to any particular anti-mitogenic
signal. We suggest that it is the combinatorial impact of these
multiple gene expression changes that deﬁnes the unique
features of each quiescent state.
Interestingly, many of the genes that initially responded in
a signal-speciﬁc manner during the initiation of quiescence
became more uniformly regulated, in a signal-independent
manner, after cells had been quiescent for 4 d. Many of these
genes ultimately made up part of the quiescence program and
are discussed below. Nevertheless, even at this late time point
each anti-proliferative signal continued to maintain cells in
unique quiescent states as evidenced by the regulation of new
signal-speciﬁc genes that suppressed growth and division in
different ways (Table 1). Thus genes essential for DNA
synthesis (POLD2), RNA synthesis (POLR2I), and protein
synthesis (EIF3S9, HARS) were uniquely downregulated by
mitogen withdrawal after 4 d of quiescence. Many genes
essential for various aspects of intermediary metabolism were
uniquely downregulated after 4 d of loss of adhesion,
including genes crucial for lipid, carbohydrate, and nucleo-
tide metabolism (Table 1). Moreover, anti-proliferative path-
ways uniquely upregulated in mitogen-starved quiescent cells
included those governed by TGF-beta 2 and -3. In contrast, loss
of adhesion induced the phosphatases Dusp4 and -5 (Map-
kinase phosphatases), which are inhibitors of the MAP-kinase
signaling pathway, whereas contact inhibition induced the
quiescent cell-speciﬁc transcription inhibitor E2F4.
One implication of our work is that it will be important to
consider the speciﬁc quiescent state from which cells are
emerging when analyzing the effects of particular proteins on
cell proliferation. It will be of interest to determine which
particular quiescent states are found in vivo, as this should
provide new insights into the mechanisms that control cell
dynamics and tissue homeostasis during embryonic develop-
ment and in mature animals. We speculate that the tissue-
speciﬁc effects of particular oncogenes and tumor suppres-
sors might be understood in terms of their functional
relationship to different quiescent states.
Quiescence Program
Superimposed on this diversity of states is a set of
transcriptional responses that is shared by all quiescent
ﬁbroblasts. While on average only 9% of genes are regulated
in any given arrest state, 78% of those regulated in four
transcriptionally distant arrest states were also regulated in
t h eﬁ f t h .S i n c et h e s ec h a n g e si ng e n ee x p r e s s i o na r e
characteristic of quiescence per se, rather than of a particular
mechanism of cell cycle arrest, we suggest that they may
represent a ﬁbroblast ‘‘quiescence program.’’ We further
deﬁne below the characteristics of quiescent cells, in addition
to cell cycle arrest, that emerge from these commonly
regulated genes.
Many of the quiescence program genes have already been
shown to play a role in controlling cell proliferation. The
upregulated protein MXI1 has been shown to control cell
proliferation in mouse models [14]. The downregulated
Figure 5. Change in Expression with Longer Arrest Time
(A) Neighbor-joining tree defining the relationship between growing cells, cells arrested by mitogen withdrawal, contact inhibition, or loss of adhesion
for 4 d, and by growth to confluence for 20 d. Transcriptional distances (Genechip suite 4.0) were determined and used to construct the distance matrix
and neighbor-joining tree as described in Figure 2A.
(B–D) Plot of expression levels in quiescence program genes in growing, 4-d confluent and 20-d confluent cells. Mean expression values in growing
cells, cells arrested by growth to confluence for 4 d and cells arrested by growth to confluence for 20 d were normalized by dividing by the average
value. The data are plotted for (B), all downregulated quiescence program genes; (C), the 89 upregulated quiescence program genes that were more
strongly upregulated at 20 d than 4 d; and (D), the 26 upregulated quiescence program genes that were more strongly upregulated at 4 d than 20 d.
(E) Heat maps of gene expression changes characteristic of longer arrest. Gene expression patterns for genes downregulated or upregulated in 20-d
confluent cells but not cells arrested by mitogen withdrawal, contact inhibition, or loss of adhesion for 4 d are shown. Heat maps were generated as
described for Figure 2C. The expected number of genes, 1.3 upregulated genes and 0.5 downregulated genes, were determined by permutation
testing. The observed values of 26 and 87, respectively, are highly significant (p   0.001).
DOI: 10.1371/journal.pbio.0040083.g005
PLoS Biology | www.plosbiology.org March 2006 | Volume 4 | Issue 3 | e83 0341
A New Description of Cellular QuiescenceTable 3. Genes Regulated by Quiescence for Longer Periods of Time
Upregulated or Downregulated Gene Name GO Term
Upregulated in 20-d confluent cells ACO1: aconitase 1, soluble Carbohydrate metabolism
B4GALT1: UDP-Gal:betaGlcNAc b-1,4- galactosyltransferase,
polypeptide 1
Carbohydrate metabolism
ME1: malic enzyme 1, NADP(þ)-dependent, cytosolic Carbohydrate metabolism
IL32: interleukin 32 cell communication, cell adhesion, immune response
PPP2R5A: protein phosphatase 2, regulatory subunit B (B56),
alpha isoform
Cell communication, signal transduction
RAB32: RAB32, member RAS oncogene family Cell communication, signal transduction
BAG1: BCL2-associated athanogene Cell communication, signal transduction
RRAS: related RAS viral (r-ras) oncogene homolog Cell communication, signal transduction,
intracellular transport
CLOCK: clock homolog Cell communication, signal transduction,
regulation of transcription
ELN: elastin Cell proliferation, development, morphogenesis
DYRK4: dual-specificity tyrosine-(Y)-phosphorylation
regulated kinase 4
Cellular protein metabolism
MLF1: myeloid leukemia factor 1 Development
KCNA4: potassium voltage-gated channel, member 4 Establishment of localization, ion transport
AP3M2: adaptor-related protein complex 3, mu 2 subunit Intracellular transport
WARS: tryptophanyl-tRNA synthetase Negative regulation of cell proliferation
Hel-N1: ELAV-like neuronal protein 1 Nothing listed
TWIST1: twist homolog 1 Nothing listed
KIAA0276 Nothing listed
FAS: Fas (TNF receptor superfamily, member 6) Nothing listed
G0S2: G0/G1switch 2 Regulation of cell cycle,
E2F5: E2F transcription factor 5, p130-binding Regulation of cell cycle, regulation of transcription
TSG101: tumor susceptibility gene 101 Regulation of cell growth
HHEX: hematopoietically expressed homeobox Regulation of transcription, development
PTX3: pentraxin-related gene Response to external stimulus, immune response
HNRPA1: heterogeneous nuclear ribonucleoprotein A1 RNA metabolism
CYP3A7: cytochrome P450, family 3, subfamily A, polypeptide 7 Xenobiotic metabolism, response to external stimulus
Downregulated in 20-d confluent cells
IGHM: immunoglobulin heavy constant mu Biological process unknown
ESD: esterase D Biological process unknown
ATXN10: ataxin 10 Biological process unknown
LPP: LIM domain containing preferred translocation
partner in lipoma
Biological process unknown
SMAP: small acidic protein Biological process unknown
COL6A2: collagen, type VI, alpha 2 Cell communication, cell adhesion
ITGA9: integrin, alpha 9 Cell communication, cell adhesion, signal transduction
LIFR: leukemia inhibitory factor receptor Cell communication, signal transduction
CSNK1A1: casein kinase 1, alpha 1 Cell communication, signal transduction
ANK2: ankyrin 2, neuronal Cell communication, signal transduction
RALGDS: ral guanine nucleotide dissociation stimulator Cell communication, signal transduction
GNB1: guanine nucleotide binding protein Cell communication, signal transduction
BMPR1A: bone morphogenetic protein receptor Cell communication, signal transduction
RAB11B: RAB11B, member RAS oncogene family Cell communication, signal transduction
GNAQ: guanine nucleotide binding protein (G protein),
q polypeptide
Cell communication, signal transduction
TRIO: triple functional domain (PTPRF interacting) Cell communication, signal transduction
CDC2L2: cell division cycle 2-like 2 (PITSLRE proteins) Cell communication, signal transduction
VIPR2: vasoactive intestinal peptide receptor 2 Cell communication, signal transduction
IQGAP1: IQ motif containing GTPase activating protein 1 Cell communication, signal transduction
ALCAM: activated leukocyte cell adhesion molecule Cell communication, signal transduction,
cell adhesion, immune response
NCK1: NCK adaptor protein 1 Cell communication, signal transduction,
cytoskeleton organization, and biogenesis
IL13: interleukin 13 Cell communication, signal transduction,
immune response
PLAU: plasminogen activator, urokinase Cell communication, signal transduction,
protein catabolism
ELK3: ELK3, ETS-domain protein Cell communication, signal transduction,
regulation of transcription
CRK: v-crk sarcoma virus CT10 oncogene homolog Cell communication, signal transduction,
regulation of transcription
PRKAR1A: protein kinase, cAMP-dependent, regulatory,
type I, alpha
Cell communication, signal transduction,
regulation of transcription
STAT6: signal transducer and activator of transcription 6 Cell communication, signal transduction,
regulation of transcription
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A New Description of Cellular QuiescenceTable 3. Continued
Upregulated or Downregulated Gene Name GO Term
PPP6C: protein phosphatase 6, catalytic subunit Cell cycle
CUL4A: cullin 4A Cell cycle arrest, negative regulation of cell cycle
CSPG4: chondroitin sulfate proteoglycan 4 Cell motility
UROD: uroporphyrinogen decarboxylase Cofactor metabolism
CALD1: caldesmon 1 Development
CALD1: caldesmon 1 Development, morphogenesis
RPA4: replication protein A4, 34kDa DNA replication
MTMR3: myotubularin related protein 3 Lipid metabolism
C8A: complement component 8, alpha polypeptide Immune response
GDF1: growth differentiation factor 1 Lipid metabolism
CHKA: choline kinase alpha Lipid metabolism
VAMP3: vesicle-associated membrane protein 3 Localization, transport
COPS8: COP9 constitutive photomorphogenic homolog subunit 8 Metabolism
GSTA2: glutathione S-transferase A2 Metabolism
LAMP1: lysosomal-associated membrane protein 1 Nothing listed
Basic Transcription Factor 2, 34 Kda Subunit Nothing listed
PGRMC1: progesterone receptor membrane component 1 Nothing listed
BCR: breakpoint cluster region Nothing listed
TAL2: T-cell acute lymphocytic leukemia 2 Nothing listed
Ptg-12 Nothing listed
TSNAX: translin-associated factor X Nothing listed
Nadh-Ubiquinone Oxidoreductase,51 Kda Subunit Nothing listed
MATR3: matrin 3 Nothing listed
CTSE: cathepsin E Nothing listed
PSMD5: proteasome (prosome, macropain)
26S subunit, non-ATPase, 5
Nothing listed
Ras Inhibitor Inf Nothing listed
MYO1C: myosin IC Nothing listed
SLC5A3: solute carrier family 5 (inositol transporters),
member 3
Nothing listed
Zinc Finger Protein, Kruppel-Like Nothing listed
ADSS: adenylosuccinate synthase Nucleotide metabolism
ATP6V1A: ATPase, Hþ transporting, lysosomal 70kDa, V1 subunit A Nucleotide metabolism, ion transport
PEX1: peroxisome biogenesis factor 1 Organelle organization and biogenesis
MMP14: matrix metallopeptidase 14 Protein catabolism
FBXO21: F-box protein 21 Protein catabolism
RBP3: retinol binding protein 3, interstitial Protein catabolism, lipid metabolism
ELA3A: elastase 3A, pancreatic Protein catabolism, lipid metabolism
SUMO1: SMT3 suppressor of mif two 3 homolog 1 Protein metabolism
PPP2R3A: protein phosphatase 2, regulatory
subunit B, alpha
Protein metabolism
PPIF: peptidylprolyl isomerase F Protein metabolism
SUMO3: SMT3 suppressor of mif two 3 homolog 3 Protein metabolism
SUMO2: SMT3 suppressor of mif two 3 homolog 2 Protein metabolism
PIGR: polymeric immunoglobulin receptor Protein secretion
BCL2L7P1: BCL2-like 7 pseudogene 1 Regulation of apoptosis
CCNE1: cyclin E1 Regulation of cell cycle
HTATIP: HIV-1 Tat interacting protein, 60kDa Regulation of cell growth,
regulation of transcription
TCF12: transcription factor 12 Regulation of transcription
CITED2: Cbp/p300-interacting transactivator Regulation of transcription
MAZ: MYC-associated zinc finger protein Regulation of transcription
ATRX: alpha thalassemia/mental
retardation syndrome X-linked
Regulation of transcription
CDK8: cyclin-dependent kinase 8 Regulation of transcription
PRKCBP1: protein kinase C binding protein 1 Regulation of transcription
ZNF266: zinc finger protein 266 Regulation of transcription
ATF2: activating transcription factor 2 Regulation of transcription
RNF2: ring finger protein 2 Regulation of transcription
ZNF9: zinc finger protein 9 Regulation of transcription
GATAD1: GATA zinc finger domain containing 1 Regulation of transcription
ZNF161: zinc finger protein 161 Regulation of transcription
CDX2: caudal type homeo box transcription factor 2 Regulation of transcription, development
MSX2: msh homeo box homolog 2 Regulation of transcription, development, morphogenesis
HBA2: hemoglobin, alpha 2 Transport, establishment of localization
ASNA1: arsA arsenite transporter, ATP-binding, homolog 1 Transport, response to external stimulus
Genes consistently regulated at 20 d of quiescence by growth to confluence but not by mitogen withdrawal, loss of adhesion, or contact inhibition for 4 d are listed along with relevant GO classifications assigned as described in Table 1.
DOI: 10.1371/journal.pbio.0040083.t003
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A New Description of Cellular Quiescenceproteins include FOXM1, which has also been shown to be
rate-limiting for cell proliferation in animal models [15]. Also
downregulated was CKS2 [16] and other proteins known to be
associated with cell proliferation, including cyclin B1, CENPA,
thymidine kinase, and thymidylate synthase. Thus, the functional
relevance of the quiescence-program gene-expression
changes with regard to cell-cycle arrest is clear.
Among the downregulated quiescence program genes were
both Cdc20 and Cul-1, indicating that quiescence involves
decreased activity of two major cell-cycle, proteolytic path-
ways, those governed by APC Cdc20 and the SCF. Note that a
different form of the APC, APC-Cdh1, is activated in
quiescent cells [17], suggesting that quiescence involves a
switch in the regulation and function of the APC.
Many of the genes upregulated in the quiescence program
are also involved in negatively controlling cell division.
Indeed, some of the upregulated genes that may be involved
in actively maintaining cell cycle arrest encode established
and putative tumor-suppressor proteins including MXI1,
TP53, FAT, transmembrane receptor PTK7, downregulated
in ovarian cancer 1 (DOC1), tyrosine phosphatase receptor
(PTPRK), N-myristoyltransferase 1 (NMT1), hypermethylated
in cancer (HIC-1), tissue inhibitor of metalloproteinases-3
(TIMP3), and cadherin 11 (CDH11). This underscores the idea
that tumorigenesis, in part, involves escape from an actively
maintained nondividing state.
The genes and pathways in the ﬁbroblast quiescence
program are also important for quiescence in other cell
types. Twenty-four of the genes we identiﬁed as being
downregulated in the ﬁbroblast quiescence program were
also studied in T lymphocytes, and 17 of those were
downregulated in quiescent versus proliferating T cells (p
  .001 by chi-squared analysis) [18] (Table 2). Moreover, 81
genes we identiﬁed as being upregulated in the ﬁbroblast
quiescence program were also studied in T lymphocytes, and
12 were expressed at higher levels in quiescent lymphocytes (p
, .01 by chi-squared analysis). It is not unexpected that there
would be less overlap among upregulated quiescence genes,
because many of them participate in cell-type speciﬁc
pathways such as intercellular communication and suppres-
sion of differentiation. We also highlight speciﬁc pathways
that are shared between quiescent ﬁbroblasts and T lympho-
cytes. One is downregulation of myc, which in ﬁbroblasts is
achieved by upregulation of the myc antagonist MXI1, and in
Figure 7. Cells Arrested by CKI Overexpression
Photographs of cells transduced with an empty vector (A), or a vector
encoding p21 (B), or p27 (C). Methods and axes are as in Figure 1.
Tetraploid cells were gated out. In cells transduced with an empty vector,
19% of the nuclei incorporated BrdU, while less than 1% of cells
expressing p21 or p27 incorporated BrdU during the same time period.
DOI: 10.1371/journal.pbio.0040083.g007
Figure 6. Combination of Arrest Signals Results in Synergistic Effects
(A) Neighbor-joining tree defining the relationship among growing cells,
cells arrested by a single signal overnight, by a combination of signals, by
single signals for 4 d and by longer arrest. Transcriptional distances
(Genechip suite 4.0) were determined and the mean transcriptional
distances for the two examples of each arrest condition were used to
construct the distance matrix and neighbor-joining tree.
(B) Mean transcriptional distance from growing cells to cells arrested by
individual signals overnight, and the sum of the distances, is plotted, and
compared with the transcriptional distance from growing cells to cells
arrested overnight by a combination of signals.
(C) The fraction of upregulated quiescence program genes that were
upregulated by each individual signal and by combinations of signals
after an overnight arrest.
DOI: 10.1371/journal.pbio.0040083.g006
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Another is modulation of the TGF-b pathway. An important
component of T cell quiescence is the TGF-b agonist TOB1
[20], and the related proteins TOB2 and BTG-2 are upregu-
lated in quiescent ﬁbroblasts.
Quiescence Is Not Only Cell-Cycle Arrest
The genes universally expressed in quiescent ﬁbroblasts
can be broadly divided into two groups. One group includes
the genes that are regulated as a downstream consequence of
cell-cycle exit, for example by inhibition of CDKs. These
genes are mostly repressed during cell-cycle arrest and many
of them encode proteins that directly participate in cell
growth and division. This suggests that feedback regulation of
cell-cycle genes is an important component of exit from the
cell cycle. In contrast, cell-cycle arrest was not sufﬁcient to
recapitulate the regulation of the second group of quiescence
genes, which included most of the upregulated quiescence
program genes. Induction of these genes was more likely to
reﬂect the engagement of a signaling pathway shared by these
extracellular arrest signals, that culminates not only in the
inhibition of proliferation, but also in other gene expression
changes that are required to actively maintain cells in a viable
and reversible state of arrest.
Reversible Arrest
The cardinal feature of quiescence that distinguishes it
from other nondividing cell states, such as senescence,
apoptosis, and terminal differentiation, is that quiescence is
reversible. Some of the genes regulated in quiescent cells may,
therefore, play roles in suppressing entry into these irrever-
sible ‘‘out-of-cycle’’ states. In particular, we showed that both
contact inhibition and serum starvation inhibited MyoD-
induced myogenesis, while cells arrested by p21 overexpres-
sion entered a myogenesis pathway with an efﬁciency similar
to controls. These results are consistent with the classical
literature on myogenesis, in which it was demonstrated that
cultured myoblasts can only initiate terminal myogenic
differentiation when they are proliferating, whereas quies-
cent myoblasts are resistant to myogenic signals [21–23]. In
the C2C12 myoblast cell line, MyoD-dependent differentia-
tion involves induction of myogenin while the cells are still
proliferating [24] followed by p21-dependent exit from the
cell cycle [25–27]. Moreover, in vivo, quiescent myogenic stem
cells (satellite cells) ﬁrst proliferate in response to muscle
injury before initiating myogenesis and differentiating to
form new myotubes [28]. Our results extend these ﬁndings to
ﬁbroblasts and show that the block to myogenesis imposed by
quiescence is at the level of responsiveness to MyoD. The p21-
induced nonproliferating state remains permissive for myo-
genesis, which may therefore explain why the p21 mode of
cell-cycle exit is utilized as part of the myogenic program.
Some of the genes regulated in quiescent cells but not cells
arrested by CDK inhibition may mediate the resistance to
differentiation through the Notch, bone morphogenetic
protein (BMP), or Wnt pathways. The upregulated gene
HES1 (hairy and enhancer of split homolog-1), a basic helix-
loop-helix (bHLH) transcriptional repressor, is a key target in
Notch signaling. It blocks nerve growth factor-induced
differentiation [29] and the myogenic differentiation proper-
ties of MyoD [30,31]. SMAD1, a signaling platform for the
BMP pathway, was also consistently upregulated in quiescent
cells. It can facilitate Notch signaling and thereby inhibit
differentiation [32]. A number of genes in the Wnt pathway,
which can suppress differentiation in stem cells [33], were
upregulated in quiescent cells including WNT2, the frizzled
receptor FZD2, TCF7L2, and p300/CBP-associated factor
(PCAF). Other gene-expression changes that may play a role
in suppressing differentiation include upregulation of BCL6
[34], upregulation of matrix Gla protein, which inhibits
chondrocyte differentiation [35], and downregulation of acyl
coenzyme A binding protein (DBI), which promotes adipocyte
differentiation [36,37]. The latter two may be particularly
important in quiescent ﬁbroblasts, which can differentiate
Figure 8. CKI Overexpression Does Not Closely Resemble the Quiescent
State Induced by Any Extracellular Signal
(A) Neighbor-joining tree of growing cells, cells arrested by extracellular
signals for 4 d, cells transduced with an empty vector, and cells
transduced with a CKI. Transcriptional distances were determined for all
pairwise comparisons (Genechip suite 5.0), and neighbor-joining trees
were drawn as described in Materials and Methods.
(B–E) The overlap between genes regulated by CKI overexpression and
genes consistently regulated by all signals (B), mitogen withdrawal (C),
contact inhibition (D), or loss of adhesion (E) was determined. The
number of regulated genes is shown within the circle. The fraction of
regulated genes within the overlap area is provided outside the circles.
Genes consistently downregulated by all three arrest signals were most
likely to be regulated by CKI overexpression.
DOI: 10.1371/journal.pbio.0040083.g008
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types of quiescent cells may express different lineage-speciﬁc
inhibitors of differentiation.
Other regulated genes may inhibit apoptosis. Upregulation
of NF-kappa B family member p49/p100 (NFKB2), which is an
inhibitor of apoptosis, was observed in cells arrested for 4 d
by all signals. Cells arrested by mitogen withdrawal upregu-
lated MET, which inhibits apoptosis [38], while downregulat-
ing Bak, an apoptosis inducer [39,40]. Cells arrested overnight
by loss of adhesion upregulated BRAG-1,aBcl-2 homologue
[41]. Cells arrested by contact inhibition upregulated FYN,
which may play a role in IGF-1–mediated survival [42].
Other upregulated genes that may function to preserve the
reversibility of quiescence are those that protect the cells
from accumulating damage. These include superoxide dis-
mutase-3 (SOD3), which scavenges free radicals [43], peroxir-
edoxin 4 (PRDX4), which protects against hydroperoxides
[44], and epoxide hydrolase (EPHX1), which detoxiﬁes
environmental chemicals.
Surprisingly, some of the genes upregulated in the
quiescence program have been previously characterized as
oncogenes, including NFKB2 [45], BCL6, and cyclin D2 [47–50].
This paradox can be resolved by appreciating that tumori-
genic cells share with quiescent cells the ability to suppress
entry into a terminally arrested state, and therefore that
oncogenic transformation should not simply be viewed as a
negation of quiescence.
Intercellular Signaling
A large number of quiescence program genes were linked
to intercellular signaling (Table S1), including cell surface
receptors that affect how quiescent ﬁbroblasts respond to
their environment, proteins involved in remodeling of the
extracellular microenvironment, secreted proteins that could
affect the proliferation of surrounding cells, and extracellular
inhibitors of angiogenesis. These gene-expression changes
suggest that quiescent ﬁbroblasts may create a growth-
suppressing microenvironment that affects not only other
ﬁbroblasts but also other neighboring cell types. Thus,
quiescence might be an organized property of the collection
Figure 9. Quiescence, but Not Simply Cell-Cycle Arrest, Protects against Differentiation
Human dermal fibroblasts 91-SF5 were transduced with a MyoD-estrogen receptor fusion, selected for stably transduced cells, and differentiated. At the
indicated time points after differentiation, myogenin (A–C) and myosin heavy chain (D–F) expression levels were determined with real time RT-PCR
using GAPDH as an internal standard and normalized values were plotted. Myogenesis marker expression induced by differentiation was inhibited in
cells that were made quiescent for 4 d by serum withdrawal (A and D) or contact inhibition (B and E) as compared with growing cells. In contrast, in cells
arrested by overexpression of the CKI p21, there was no reduction in myogenesis marker expression as compared with control cells transduced with an
empty vector (C and F).
DOI: 10.1371/journal.pbio.0040083.g009
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A New Description of Cellular Quiescenceof cells that comprise a tissue or organ, rather than a strictly
cell-autonomous process. Fibroblasts in tumors, unlike
ﬁbroblasts in normal tissues, frequently express genes
characteristic of proliferating as opposed to serum-starved,
quiescent cells [51]. Tumor progression, then, could be
viewed as a disruption in the quiescent state maintained in
the entire tissue, and reﬂect changes not only in the tumor
cells themselves, but also in the surrounding stroma and the
vasculature.
Materials and Methods
Cells. Fetal human lung diploid ﬁbroblasts from American Type
Culture Collection (CCL153) were grown in FBM medium (Biowhit-
taker, Walkersville, Maryland, United States) supplemented with 2%
fetal calf serum, 5 lg/ml insulin, and 1 ng/ml ﬁbroblast growth factor
(FGMmedium).Cellsweregrownat378Cin5%CO 2androutinelysplit
1to3every3d.Foreachcondition,frozenaliquotsof5310
6cellswere
expandedforﬁvepassages,andapproximately4310
7cellswereplated
in the given condition.
Arrest conditions. For growing cultures, cells were plated at a
density of 2310
4 cells per cm
2 in FGM medium and allowed to attach
to the tissue culture plate. Because we wanted to explore the effects
of mitogen withdrawal on the cell cycle without the many other
effects of changes in serum concentrations, cells were grown or
arrested in low-serum conditions in the presence or absence of the
mitogen platelet-derived growth factor (PDGF). The medium was
changed to FBM with 0.1% fetal calf serum, 25 ng/ml IGF-1 (R&D
Systems, Minneapolis, Minnesota, United States), and 30 ng/ml PDGF
(R&D Systems). Cells arrested by mitogen withdrawal were plated at a
concentration of 10
4 cells/cm
2 and allowed to attach to the tissue
culture plate. The medium was changed to FBM, 0.1% serum, and
IGF-1. To arrest cells by loss of adhesion, tissue culture plates were
coated with FBM medium containing 1% agarose that was allowed to
solidify to prevent cells from attaching to the plate. Cells were placed
in a suspension of FBM, 0.1% serum, IGF-1 and PDGF supplemented
with 0.4% methylcellulose (Fisher Scientiﬁc, Fair Lawn, New Jersey,
United States). For cells arrested by contact inhibition, the cells were
plated at 2 3 10
5 cells/cm
2 and allowed to attach before the medium
was changed to 0.1% serum, IGF-1 and PDGF. Cells were incubated
either for 14 h or for 4 d with medium changes every 2 d. For arrest
by growth to conﬂuence, cells were plated at a density of 2310
4 cells
per cm
2 in FGM and allowed to grow to conﬂuence. Medium was
changed every 2 to 3 d for 4 d or approximately 20 (17–22) d. The
night before cells were collected for ﬂow cytometry, the medium was
changed to FBM, 0.1% serum, IGF-1 and PDGF. For each condition,
two independent replicates were performed.
Arrest via CKI overexpression. To arrest CCL153 by CKI over-
expression, Phoenix cells (American Type Culture Collection,
Manassas, Virginia, United States) were transfected with QCXIP
empty vector or QCXIP into which the coding sequence of p21 or p27
had been introduced with fugene (Roche, Indianapolis, Indiana,
United States). Due to a change in the termination codon, the p21
vector expresses a protein that is 6-kDa larger than p21 at its C
terminus. The viral supernatants from transduced Phoenix cells were
collected 48 h later and used to transduce ﬁbroblasts. Two days after
transduction, the cells were selected with 5 lg/ml puromycin for 2 d.
The night before cells were collected for ﬂow cytometry, the medium
was changed to FBM, 0.1% serum, IGF-1 and PDGF.
Bromodeoxyuridine labeling. Cells were labeled with 100-lM
bromodeoxyuridine (BrdU) for 6 h. Cells were collected with trypsin.
The trypsin was inactivated with serum, and cells were ﬁxed in PBS
with 67% cold ethanol. Cell membranes were lysed at 37 8C in 0.08%
pepsin for 20 min, and nuclei were treated with 2M HCl for 20 min.
Samples were neutralized with 0.1M sodium borate, then incubated in
a buffer of 10 mM Hepes, (pH7.4), 150 mM NaCl, 4% fetal bovine
serum, and 2 lg of anti-BrdU-FITC antibody (Pharmingen, San
Diego, California, United States) on ice for 2 h. The antibody was
removed and cells were incubated in the same buffer with 0.5%
Tween-20, 250 lg/ml RNase A, 100 lg/ml propidium iodide, and
analyzed on a Beckton Dickinson FACS Calibur (Becton Dickinson,
Palo Alto, California, United States).
Flow cytometry. Cells were incubated with approximately 5 lg/ml
Hoescht 33342 (Calbiochem-Novabiochem, San Diego, California,
United States) for 45 min. Cells were treated with trypsin and
collected into 1 mg/ml soybean trypsin inhibitor (Sigma, St. Louis,
Missouri, United States), centrifuged and resuspended in Hanks
balanced saline solution supplemented with BSA (100 mg/ml), gelatin
(0.04%), and EGTA (5M). Propidium iodide (0.5 lg/ml) was added, and
the cells were incubated on ice. For cells arrested by mitogen
withdrawal for 4 d, Hoescht was not applied because it induced cell
death. Samples were run on a Beckton Dickinson FACS Vantage SE.
Microarray analysis. RNA was converted into target and hybridized
to HuGENE-FL microarrays as described previously [52]. Microarray
results were analyzed with the GENECHIP software (Affymetrix suite
4.0 or 5.0, Affymetrix, Santa Clara, California, United States). Each
chip was scaled such that the average intensity was 1,000 while
masking outliers (suite 4.0) or 500 (suite 5.0). Because of differences in
the overall intensity of the different chips used in these experiments,
only genes with average difference values in the ﬁrst growing sample
between ten and 6,700 were considered for analysis. This resulted in
the systematic exclusion of classes of proteins expressed at high levels,
for instance, ribosomal proteins.
Neighbor-joining trees. The transcriptional distance between two
samples was determined for each pair of samples as the sum of the log
base two of the absolute values of the fold changes for each gene, or
the sum of the signal log ratios. This value was assigned a zero for a
particular gene if there was a ‘‘no change’’ call between the samples
or if the gene was absent in both samples. The distance matrix was
used to create neighbor-joining trees with the Phylip software suite
version 3.5 (available at http://www.evolution.genetics.washington.
edu/phylip/software.html).
Identifying regulated genes. In the ﬁrst method, we required that
all of the gene expression values were higher or lower in the regulated
samples as compared with all samples in which the gene was not
regulated. We then required that the change in gene expression met a
2-fold cutoff under regulated conditions but did not change 2-fold in
unregulated conditions. 2-fold cutoffs were assessed by comparing
arrested state replicate 1 to growing sample replicate 1 and arrested
state replicate 2 to growing sample replicate 2. To avoid dividing by
small or negative numbers, average difference values less than 20
were thresholded to a value of 20. The number of genes expected by
chance was determined by performing the same analysis on the same
data set with permuted column headings. For prolonged arrest, we
only used the 2-fold cutoff approach.
In the second method, we used a template-matching approach
described in more detail previously [52]. An idealized template vector
consisting of zeroes and ones was compared with the vector of
average difference values for all of the genes that passed the ﬁlter,
and the Pearson correlation coefﬁcient was computed [53]. Genes
that matched the template better than was ever observed in 20
permutations of the entire data set (0.05 genes expected) were
included in the list of consistently regulated genes.
The total number of false positives expected (the sum of the
number expected from both methods) was compared with the
observed number of regulated genes based on a Poisson distribution.
Deﬁning a quiescence program: the expression values in all 4-d or
longer samples were required to be higher or lower than the values in
the growing samples or the growing samples with an empty vector. In
permuted data, 1.4 upregulated and 3.4 downregulated genes met
these criteria. In contrast, 205 genes were expressed at a higher level
in all longer arrested states, and 59 genes were expressed at a lower
level in all longer arrested states. We then required that the gene
expression value in each of the longer arrested states was consistently
2-fold higher than in growing cells. There were 43 upregulated genes
that met these criteria and 16 downregulated genes, whereas 0.1
upregulated and 0.1 downregulated genes were expected by chance.
To this list of consistently regulated genes, we added genes that
met the template-matching criteria for eight different templates. The
templates were deﬁned by higher (or lower) expression in all arrests
for 4 or 20 d, and all combinations of regulation in the same direction
in subsets of overnight samples. For each template, genes with
Pearson correlation coefﬁcients closer to  1 or 1 than observed for
any gene when the entire data set was permuted 203 were included.
These eight different template-matching tests resulted in a total of 98
upregulated genes and 30 downregulated genes when 0.4 (8 3 .05)
genes were expected by chance. The total number of quiescence
program genes when the two lists were merged was 116 upregulated
and 33 downregulated.
Myogenesis. For myogenesis experiments, Phoenix cells were
transfected with pBabe-MyoD-ER, and the supernatant was used to
transduce human dermal ﬁbroblasts 91-SF5 (generous gift of T.
Norwood, University of Washington, Seattle, Washington, United
States), as described above. 91-SF5 cells were grown in phenol red-
free DMEM, supplemented with 10% bovine growth serum (Hyclone,
Logan, Utah, United States), and were selected with 2 lg/ml
puromycin for 2 d. To induce differentiation, 91-SF5 cells transduced
with pBabe-MyoD-ER were washed twice with PBS and the medium
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transferrin (10 lg/ml, Sigma), horse serum (0.5%, or 0.2% for serum-
starved samples, Gibco/Invitrogen, Carlsbad, California, United
States), and b-estradiol (10
 7 M; Sigma). For serum-starved samples,
cells were incubated in phenol red-free DMEM with no serum for 4 d
prior to differentiation. For contact-inhibited samples, cells were
plated at high density (2 3 10
5 cells/cm
2) and incubated for 4 d prior
to differentiation. For CDK inhibition, 91-SF5 cells were transduced
with a pBabe-MyoD-ER vector containing a gene-encoding hygrom-
ycin resistance, and selected with hygromycin (250 lg/ml). Cells were
then transduced with either the QCXIP empty vector or QCXIP
containing the p21 coding sequence, and selected with puromycin (2
lg/ml). Cells were then induced to differentiate. Samples were
collected into Trizol reagent at the indicated times for real-time
RT-PCR.
For real-time RT-PCR, RNA was isolated as described above. cDNA
was synthesized from 2 lg of total RNA using Superscript II reverse
transcriptase (Invitrogen) primed with poly-T oligonucleotides
according to the manufacturer’s instructions. One-tenth the ﬁnal
volume was used for real-time PCR with master-mix–containing
primers and probes speciﬁc for myosin heavy chain (ID number
Hs00428600_m1, Applied Biosystems, Foster City, California, United
States). Real-time PCR was performed on an ABI Prism 7900
instrument. Samples were normalized for expression levels of human
GAPDH (Applied Biosystems).
Supporting Information
Figure S1. Persistence of Gene Expression Changes from 14 h to 4 d
Using template-matching, the number of genes upregulated and
downregulated by mitogen withdrawal (A), contact inhibition (B), and
loss of adhesion (C) was determined based on a Pearson correlation
coefﬁcient threshold of two genes by chance. For each arrest signal,
the number of genes regulated by only an overnight arrest, by both
overnight and 4 d, and only 4 d was determined. A signature was
considered present if more than seven genes were included. Data are
normalized and depicted as heat maps generated with Java Treeview.
Found at DOI: 10.1371/journal.pbio.0040083.sg001 (2.2 MB PDF).
Figure S2. Genes Regulated in Opposite Directions by Mitogen
Withdrawal and Loss of Adhesion
Genes upregulated by mitogen withdrawal and downregulated by loss
of adhesion, and vice versa, were identiﬁed by template-matching
using a threshold of two genes by chance. The signatures at quiescence
initiation and quiescence maintenance are shown as heat maps.
Found at DOI: 10.1371/journal.pbio.0040083.sg002 (2.6 MB TIF).
Table S1. Quiescence Genes Involved in Intercellular Communication
Genes regulated by one, two, or three signals at 14 h, 4 d, or 20 d that
are involved in intercellular communication are listed, along with
their classiﬁcation by functional category.
Found at DOI: 10.1371/journal.pbio.0040083.st001 (232 KB DOC).
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